These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 3106694)

  • 1. Role of interleukin-2 (IL-2) and IL-2 receptor expression in the proliferative defect observed in mitogen-stimulated lymphocytes from patients with gliomas.
    Elliott L; Brooks W; Roszman T
    J Natl Cancer Inst; 1987 May; 78(5):919-22. PubMed ID: 3106694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokinetic basis for the impaired activation of lymphocytes from patients with primary intracranial tumors.
    Elliott LH; Brooks WH; Roszman TL
    J Immunol; 1984 Mar; 132(3):1208-15. PubMed ID: 6319491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of receptors for interleukin 2: Role in the commitment of T lymphocytes to proliferate.
    Lipkowitz S; Greene WC; Rubin AL; Novogrodsky A; Stenzel KH
    J Immunol; 1984 Jan; 132(1):31-7. PubMed ID: 6418801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin 2 receptor expression by activated HNK-1+ granular lymphocytes: a requirement for their proliferation.
    Abo T; Miller CA; Balch CM; Cooper MD
    J Immunol; 1983 Oct; 131(4):1822-6. PubMed ID: 6413578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of interleukin 2 and T11 E rosette antigen in activation and proliferation of human NK clones.
    Schmidt RE; Hercend T; Fox DA; Bensussan A; Bartley G; Daley JF; Schlossman SF; Reinherz EL; Ritz J
    J Immunol; 1985 Jul; 135(1):672-8. PubMed ID: 3923116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo administration of purified human interleukin-2 to patients with cancer: development of interleukin-2 receptor positive cells and circulating soluble interleukin-2 receptors following interleukin-2 administration.
    Lotze MT; Custer MC; Sharrow SO; Rubin LA; Nelson DL; Rosenberg SA
    Cancer Res; 1987 Apr; 47(8):2188-95. PubMed ID: 3030546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased interleukin-2 receptor expression after mitogen stimulation on CD4- and CD8-positive lymphocytes and decreased interleukin-2 production in HTLV-III antibody-positive symptomatic individuals.
    Creemers PC; O'Shaughnessy M; Boyko WJ
    Immunology; 1986 Dec; 59(4):627-9. PubMed ID: 3100439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired expression of high affinity interleukin 2 receptor on activated lymphocytes from patients with systemic lupus erythematosus.
    Ishida H; Kumagai S; Umehara H; Sano H; Tagaya Y; Yodoi J; Imura H
    J Immunol; 1987 Aug; 139(4):1070-4. PubMed ID: 3112222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inability of mitogen-activated lymphocytes obtained from patients with malignant primary intracranial tumors to express high affinity interleukin 2 receptors.
    Elliott LH; Brooks WH; Roszman TL
    J Clin Invest; 1990 Jul; 86(1):80-6. PubMed ID: 2365829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-2 receptor expression in retrovirus associated adult T-cell leukemia.
    Waldmann TA; Leonard WJ; Depper JM; Krönke M; Goldman CK; Oh T; Greene WC
    Princess Takamatsu Symp; 1984; 15():259-68. PubMed ID: 6100644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro analysis of the proliferative potential of T cells from patients with brain tumor: glioma-associated immunosuppression unrelated to intrinsic cellular defect.
    McVicar DW; Davis DF; Merchant RE
    J Neurosurg; 1992 Feb; 76(2):251-60. PubMed ID: 1730954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal antibody OKT11A inhibits and recombinant interleukin 2 (IL 2) augments expression of IL 2 receptors at a pretranslational level.
    Reed JC; Greene WC; Hoover RG; Nowell PC
    J Immunol; 1985 Oct; 135(4):2478-82. PubMed ID: 3928749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blockade of the interleukin-2 receptor by anti-Tac antibody: inhibition of human lymphocyte activation.
    Depper JM; Leonard WJ; Robb RJ; Waldmann TA; Greene WC
    J Immunol; 1983 Aug; 131(2):690-6. PubMed ID: 6408186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of T lymphocyte subpopulations responsible for deficient interleukin 2 activity in patients with systemic lupus erythematosus.
    Murakawa Y; Takada S; Ueda Y; Suzuki N; Hoshino T; Sakane T
    J Immunol; 1985 Jan; 134(1):187-95. PubMed ID: 3917275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of interleukin-2 (IL-2) in cancer-related immune deficiency: in vitro response to IL-2, production of IL-2, and IL-2 receptor expression in patients with advanced cancer.
    Mantovani G; Coiana A; Massidda A; Proto E; Floris C; Macciò A; Pusceddu G; Del Giacco GS
    Cancer Detect Prev; 1988; 12(1-6):149-59. PubMed ID: 3263194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is there correlation of T cell proliferative functions and surface marker phenotypes in patients with acquired immune deficiency syndrome or lymphadenopathy syndrome?
    Gluckman JC; Klatzmann D; Cavaille-Coll M; Brisson E; Messiah A; Lachiver D; Rozenbaum W
    Clin Exp Immunol; 1985 Apr; 60(1):8-16. PubMed ID: 3924452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunologic effects of interleukin 2 in primary immunodeficiency diseases.
    Flomenberg N; Welte K; Mertelsmann R; Kernan N; Ciobanu N; Venuta S; Feldman S; Kruger G; Kirkpatrick D; Dupont B; O'Reilly R
    J Immunol; 1983 Jun; 130(6):2644-50. PubMed ID: 6222111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pokeweed mitogen-induced immunoglobulin secretion by peripheral blood lymphocytes from patients with primary intracranial tumors. Characterization of T helper and B cell function.
    Roszman TL; Brooks WH; Steele C; Elliott LH
    J Immunol; 1985 Mar; 134(3):1545-50. PubMed ID: 3155771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms underlying T-lymphocyte activation: mitogen initiates and IL-2 amplifies the expression of transferrin receptors via intracellular iron level.
    Pelosi-Testa E; Samoggia P; Giannella G; Montesoro E; Caravita T; Salvo G; Camagna A; Isacchi G; Testa U; Peschle C
    Immunology; 1988 Jun; 64(2):273-9. PubMed ID: 3134296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormal expression of interleukin-2 receptor (Tac antigen) in adult T-cell leukemia.
    Uchiyama T; Wano Y; Tsudo M; Umadome H; Hori T; Tamori S; Uchino H; Yodoi J; Maeda M; Kobayashi N
    Princess Takamatsu Symp; 1984; 15():253-8. PubMed ID: 6100643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.